The Safety and Intraocular Pressure–Lowering Efficacy of Brimonidine Tartrate 0.15% Preserved with Polyquaternium-1
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 113 (8) , 1333-1339
- https://doi.org/10.1016/j.ophtha.2006.03.025
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Safety of β-adrenergic blocker washout period in clinical trialsActa Ophthalmologica Scandinavica, 2009
- Twelve-Month Evaluation of Brimonidine-Purite Versus Brimonidine in Patients With Glaucoma or Ocular HypertensionJournal of Glaucoma, 2002
- A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trialClinical Therapeutics, 2001
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000
- A 1-Year Study of Brimonidine Twice Daily in Glaucoma and Ocular HypertensionArchives of Ophthalmology (1950), 1997